Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

In this study, we examined the hypothesis that heat shock proteins (hsp) (such as hsp72 and hsp90) are implicated in the regulation of forms of cell injury that lead to programmed cell death. The monoblastoid cell line U937 has been used as a model system. For hsp90, which is not heat inducible in this cell line, we used stable U937 transfectants that either hyperexpress or hypoexpress the protein. For hsp72 (which is reproducibly induced in all three cell lines to relatively high levels of expression), we studied U937 cells before and after heat shock. We showed that apoptosis does occur in the monoblast/mononuclear phagocyte lineage, and that it could be induced in vitro by serum deprivation, UV light, or TNF-alpha in combination with cycloheximide (cx). However, an excess of hsp90 is associated with increased apoptosis when the cells are treated with a combination of TNF-alpha and cx but not when they are exposed to UV B radiation. This was complemented by the finding that reduced hsp90 levels correlate with protection against apoptosis in the TNF-alpha- and cx-treated cells. Furthermore, new synthesis of hsp72 does not protect against apoptosis. Thus, hsp90 levels may play a role in controlling the part played by mononuclear phagocytes in immunopathology.

Type

Journal article

Journal

Journal of immunology (Baltimore, Md. : 1950)

Publication Date

11/1996

Volume

157

Pages

4109 - 4118

Addresses

Department of Immunology, University College London Medical School, United Kingdom.

Keywords

Humans, Cycloheximide, Tumor Necrosis Factor-alpha, Heat-Shock Proteins, Neoplasm Proteins, Recombinant Fusion Proteins, Antigens, CD, Culture Media, Serum-Free, Transfection, Ultraviolet Rays, Apoptosis, Gene Expression Regulation, Neoplastic, Drug Synergism, Drug Resistance, HSP90 Heat-Shock Proteins, HSP72 Heat-Shock Proteins, Lymphoma, Large B-Cell, Diffuse